12.07.2015 Views

ANNUAL REPORT 06 - Bosnalijek dd

ANNUAL REPORT 06 - Bosnalijek dd

ANNUAL REPORT 06 - Bosnalijek dd

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

“It is my pleasure to mention the growth of income from sale of 2.82%, especially growth of export of54.19% and growth of net income of 2.42% in relation to previous financial year.“Dear shareholders, esteemed partners, honourable employees,We finished year 20<strong>06</strong> once morel with successful business operations,thus continuing a continuous trend of growth and development that hasbeen the characteristic of <strong>Bosnalijek</strong> in last ten years.Accomplished business results are even more significant being realised invery unpleasant business surrounding with expressive influence of manyfactors, both those specific for pharmaceutical industry at world level,and those specific for our country due to inadequate legal regulation thatwould stimulate development of domestic manufacture and strengthenits competitiveness at international market.In that sense, it is my pleasure to mention the growth of income from saleof 2.82%, especially growth of export of 54.19% and growth of netincome of 2.42% in relation to previous financial year.A greater level of investing into development of new products, clinicaltrials and registrations in the country and abroad of 18.98% is especiallyimportant indicator for our company, because this is investment into asafe and prosperous future.With regard to investments, a year behind us was in the spirit of investinginto new equipment and new technologies, what will contribute to ourefforts directed to constant improvement of quality of our products,increase of our total business excellence and manufacture of new modernmedicines.During year 20<strong>06</strong>, <strong>Bosnalijek</strong> shares were the shares that were mostlytraded at the Sarajevo Stock Exchange. In the end of year, <strong>Bosnalijek</strong>share has reached the value of 38 KM, what represents a growth of 67%in relation to end of previous year.<strong>Bosnalijek</strong> business success is the result of a driving energy of itsprofessional and motivated employees, into whose development weconstantly invest.We continuously develop partner relation with the social communitybecause we believe that <strong>Bosnalijek</strong> social responsibility is wider than itsbasic activity.In accordance with our mission, we realised social activities in previousyear through various forms of acting in the field of education, science,culture, sports and humanitarian action taking care about quality ofhuman life.We gave scholarships to 174 pupils and students, thus stimulatingeducation and studying of perspective young people, of whom some willtomorrow be the driving force of <strong>Bosnalijek</strong>.Commitment to quality and recognising the needs of our products' usersoffer us safety that <strong>Bosnalijek</strong> will also in future successfully respond tochallenges of demanding international market, working at the satisfactionof employees, shareholders and wider social community.Edin ArslanagićChief Executive Officerserving Your health COMPANY CEO's LET TER <strong>ANNUAL</strong> <strong>REPORT</strong> <strong>06</strong> 5

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!